NCT00843882 2026-03-18Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and AnemiaNational Cancer Institute (NCI)Phase 3 Active not recruiting247 enrolled 19 charts
NCT01243944 2019-03-06Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)Incyte CorporationPhase 3 Completed222 enrolled 21 charts